Levothroid and Voriconazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levothroid (levothyroxine sodium) and Voriconazole (voriconazole). Common drug interactions include deep vein thrombosis among females and acute respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Levothroid and Voriconazole. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Levothroid?

Levothroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 8,974 Levothroid users. Check the latest studies of Levothroid.

What is Voriconazole?

Voriconazole has active ingredients of voriconazole. It is often used in aspergillosis. eHealthMe is studying from 21,706 Voriconazole users. Check the latest studies of Voriconazole.

On Jul, 14, 2026

11 people who take Levothroid and Voriconazole together, and have interactions are studied.

Levothroid and Voriconazole drug interactions.

What are the common drug interactions of Levothroid and Voriconazole, by gender? *:

female:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Pyrexia (fever)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Back pain
Memory impairment
Mobility decreased (ability to move is reduced)
Osteomyelitis (infection of bone)
Phlebitis (inflammation of the walls of a vein)
Speech disorder
Spinal cord abscess (pus in spinal cord)

male:

Acute respiratory failure
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Drug effect decreased
Fungal infection
Haemorrhage (bleeding)
Hypotension (abnormally low blood pressure)
Pneumonia
Pulmonary haemorrhage (acute bleeding from the lung)
Sepsis (a severe blood infection that can lead to organ failure and death)
Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)

What are the common drug interactions of Levothroid and Voriconazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Drug resistance (reduction in effectiveness of a drug)
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)

50-59:

Local swelling (swelling at the site of some application of substance or injury)
Neck pain
Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
Pyrexia (fever)

60+:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Back pain
Spinal cord abscess (pus in spinal cord)
Weight decreased
Blood calcium decreased
Blood magnesium decreased
Blood potassium decreased
Heart rate increased
Platelet count decreased
Streptococcal sepsis (whole body inflammation by streptococcal)

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 7 people, 63.64%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 63.64%
Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 63.64%
Pain: 7 people, 63.64%
Joint Pain: 6 people, 54.55%
Blood Pressure Diastolic Increased: 6 people, 54.55%
Immunodeficiency: 5 people, 45.45%
Streptococcal Infection: 4 people, 36.36%
Multiple Myeloma (cancer of the plasma cells): 4 people, 36.36%
Infection: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Levothroid and Voriconazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously